Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Understanding why budgets fail can help you avoid common mistakes. Explore these reasons to strengthen your budgeting approach.
20,131 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Central markets abroad account for roughly half of global market capitalization. BKIE offers ultra-low-cost access to...
Rhode Island housing reform advocates take stock after a truncated 2026 session ended without top-priority reform, se...
February delivered a sharp setback for AMZN as investors weighed another wave of capital spending against growth pros...
A new NVIDIA-backed player has stepped into the high-growth AI photonics space, challenging traditional data-center b...
A high-profile PR moment turns into a money lesson. This article breaks down how rumors affect finances and what ever...
A leading market strategist argues the AI-led pullback is routine profit-taking after a rapid rally, with the AI infr...
Axos Financial has delivered a notable 12-month gain, with a recent fund trim adding a twist to the story. This artic...
Swell has halted its Swellchain on the Optimism Superchain, leaving users scrambling to recover assets as the latest ...
A gold miner’s stock has doubled in 12 months and just raised its dividend by 60%. This deep-dive explains what drive...
SBI Group unveils JPYSC, the first trust-bank-backed yen stablecoin in Japan, with a 1:1 peg to the yen and no transa...
Harvard Management Company disclosed a strategic reallocation of its crypto portfolio, trimming Bitcoin ETF exposure ...